Cl.ClC1C=CC(NN)=CC=1.BrCCC1CCCC1.[Cl:19][C:20]1[CH:25]=[CH:24][C:23]([N:26]([CH2:28][CH2:29][CH:30]2[CH2:34][CH2:33][CH2:32][CH2:31]2)N)=[CH:22][CH:21]=1.C(OC(OCC)CCCNC)C.ClC1C=C2[C:54](=CC=1)[N:53]([CH2:57][CH2:58][CH:59]1[CH2:63][CH2:62]CC1)C=C2CCNC.C=O.C(O)(C(F)(F)F)=O>[Cl-].C([N+](CCCC)(CCCC)CCCC)CCC.C(#N)C>[Cl:19][C:20]1[CH:25]=[C:24]2[C:23](=[CH:22][CH:21]=1)[N:26]([CH2:28][CH2:29][CH:30]1[CH2:34][CH2:33][CH2:32][CH2:31]1)[C:63]1[CH2:62][N:53]([CH3:54])[CH2:57][CH2:58][C:59]2=1The title compound was prepared by following General Methods 2, 3 and 4 using 4-chlorophenylhydrazine hydrochloride, (2-bromoethyl)cyclopentane, and tetra-n-butylammonium chloride (General Method 2), 1-(4-chlorophenyl)-1-(2-cyclopentylethyl)hydrazine (Example 4) and 4,4-diethoxy-N-methylbutan-1-amine (General Method 3) and 2-(5-chloro-1-(2-cyclopentylethyl)-1H-indol-3-yl)-N-methylethanamine (Example 13), formaldehyde and TFA in acetonitrile (General Method 4).
読み込み中…